Hye Shin Chung

Title: Hye Shin Chung: Innovator in Protein Engineering

Introduction

Hye Shin Chung is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of protein engineering, particularly in the development of fusion proteins and long-acting human growth hormones. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Hye Shin Chung's latest patents include a method for producing a fusion protein having an IgG Fc domain. This invention focuses on a method that enhances the productivity and quality of the fusion protein by culturing cells at a decreased temperature, which improves cell growth and viability while inhibiting aggregate generation. Another notable patent is for a method of purifying a long-acting human growth hormone, known as NexP-hGH. This invention details a specific isoform of the hormone that is fused with a highly glycosylated alpha-1 antitrypsin mutant, which increases its long-acting properties in vivo. The purification method involves multiple chromatography steps to achieve high purity for the NexP-hGH protein.

Career Highlights

Throughout his career, Hye Shin Chung has worked with notable companies such as Alteogen, Inc. and CJ Healthcare Corporation. His experience in these organizations has allowed him to refine his expertise in protein production and purification techniques.

Collaborations

Hye Shin Chung has collaborated with esteemed colleagues, including Soon Jae Park and Sun Ah You. These partnerships have contributed to the advancement of his research and innovations in the field.

Conclusion

Hye Shin Chung is a distinguished inventor whose work in protein engineering has led to significant advancements in the production and purification of therapeutic proteins. His contributions are poised to make a lasting impact in the medical field.